Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Familial severe psychiatric history in bipolar disorder and correlation with disease severity and treatment response.
Köhler-Forsberg O, Sylvia LG, Ruberto VL, Kuperberg M, Shannon AP, Fung V, Overhage L, Calabrese JR, Thase M, Bowden CL, Shelton RC, McInnis M, Deckersbach T, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Iosifescu DV, McElroy S, Ostacher MJ, Nierenberg AA. Köhler-Forsberg O, et al. Among authors: ostacher mj. J Affect Disord. 2020 Aug 1;273:131-137. doi: 10.1016/j.jad.2020.03.157. Epub 2020 May 16. J Affect Disord. 2020. PMID: 32421593
Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder.
Sylvia LG, Reilly-Harrington NA, Leon AC, Kansky CI, Ketter TA, Calabrese JR, Thase ME, Bowden CL, Friedman ES, Ostacher MJ, Iosifescu DV, Severe J, Keyes M, Nierenberg AA. Sylvia LG, et al. Among authors: ostacher mj. Clin Trials. 2012 Feb;9(1):94-101. doi: 10.1177/1740774511427324. Epub 2011 Nov 10. Clin Trials. 2012. PMID: 22076437 Free PMC article. Clinical Trial.
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.
Nierenberg AA, Friedman ES, Bowden CL, Sylvia LG, Thase ME, Ketter T, Ostacher MJ, Leon AC, Reilly-Harrington N, Iosifescu DV, Pencina M, Severe JB, Calabrese JR. Nierenberg AA, et al. Among authors: ostacher mj. Am J Psychiatry. 2013 Jan;170(1):102-10. doi: 10.1176/appi.ajp.2012.12060751. Am J Psychiatry. 2013. PMID: 23288387 Clinical Trial.
The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorder.
Sylvia LG, Rabideau DJ, Nierenberg AA, Bowden CL, Friedman ES, Iosifescu DV, Thase ME, Ketter T, Greiter EA, Calabrese JR, Leon AC, Ostacher MJ, Reilly-Harrington N. Sylvia LG, et al. Among authors: ostacher mj. J Affect Disord. 2014 Dec;169:144-8. doi: 10.1016/j.jad.2014.08.019. Epub 2014 Aug 20. J Affect Disord. 2014. PMID: 25194782 Free PMC article. Clinical Trial.
A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR).
Ostacher MJ, Nierenberg AA, Rabideau D, Reilly-Harrington NA, Sylvia LG, Gold AK, Shesler LW, Ketter TA, Bowden CL, Calabrese JR, Friedman ES, Iosifescu DV, Thase ME, Leon AC, Trivedi MH. Ostacher MJ, et al. J Psychiatr Res. 2015 Dec;71:126-33. doi: 10.1016/j.jpsychires.2015.10.004. Epub 2015 Oct 9. J Psychiatr Res. 2015. PMID: 26476489 Free PMC article. Clinical Trial.
White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder.
Köhler O, Sylvia LG, Bowden CL, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, Nierenberg AA. Köhler O, et al. Among authors: ostacher mj. Aust N Z J Psychiatry. 2017 Apr;51(4):355-365. doi: 10.1177/0004867416644508. Epub 2016 Jul 11. Aust N Z J Psychiatry. 2017. PMID: 27126391 Free article. Clinical Trial.
Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials.
Köhler-Forsberg O, Sylvia LG, Bowden CL, Calabrese JR, Thase ME, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, Nierenberg AA. Köhler-Forsberg O, et al. Among authors: ostacher mj. Acta Neuropsychiatr. 2019 Aug;31(4):230-234. doi: 10.1017/neu.2019.19. Epub 2019 Jun 6. Acta Neuropsychiatr. 2019. PMID: 31169098
Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-response.
Köhler-Forsberg O, Sloth KH, Sylvia LG, Thase M, Calabrese JR, Tohen M, Bowden CL, McInnis M, Kocsis JH, Friedman ES, Ketter TA, McElroy SL, Shelton RC, Iosifescu DV, Ostacher MJ, Nierenberg AA. Köhler-Forsberg O, et al. Among authors: ostacher mj. Psychiatry Res. 2021 Nov;305:114194. doi: 10.1016/j.psychres.2021.114194. Epub 2021 Aug 29. Psychiatry Res. 2021. PMID: 34500184 Free article. Clinical Trial.
Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment response.
Kuperberg M, Köhler-Forsberg O, Shannon AP, George N, Greenebaum S, Bowden CL, Calabrese JR, Thase M, Shelton RC, McInnis M, Deckersbach T, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Iosifescu DV, Ostacher MJ, Sylvia LG, McElroy SL, Nierenberg AA. Kuperberg M, et al. Among authors: ostacher mj. J Affect Disord. 2022 Mar 1;300:41-49. doi: 10.1016/j.jad.2021.12.047. Epub 2021 Dec 21. J Affect Disord. 2022. PMID: 34952123 Clinical Trial.
98 results